SlideShare a Scribd company logo
Ventral hippocampal corticosterone:
Linking stress, accumbal dopamine output, and reward salience
in healthy conditions and in amphetamine withdrawal
Brenna Bray, Matthew Weber, and Gina L. Forster
Center for Brain and Behavior Research, Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota
References
Acknowledgements
Grant support: NIH grant RO1 DA019921. Special thanks to Jamie Scholl, Michael Watt, PhD,
Wenyu Tu, Dana Turgeon, and Raisul Rubel for their invaluable help.
Conclusions
• In drug-naive rats, vHipp CORT enhances accumbal dopamine
output, peaking 55 min post infusion (Fig 3).
• This suggests a novel mechanism by which stress exposure
could enhance reward value to promote goal-oriented
behavior1,14 (Fig 1).
• In AMP WD, vHipp CORT immediately reduces accumbal dopamine
output, peaking 20 min and then 80 min post-infusion (Fig 3).
• This suggests stress-induced vHipp CORT could contribute to
dysphoric states that prompt drug-seeking and relapse during
withdrawal (Fig 4A)2-4.
• These findings support an opponent-process theory of
addiction, in which blunted dopamine reward responses and
enhanced CORT stress responses contribute to negative
reinforcement of drug-taking (Fig 4A)2.
Discussion
• CORT activation of glucocorticoid receptors (GRs) is thought to be
excitatory in the vHipp7-8,11,, implicating GRs as the underlying
mechanism for the CORT-induced dopamine output (Fig 3).
• GR expression is reduced in the vHipp during AMP WD, but vHipp
mineralocorticoid receptor (MR) expression is not altered (Fig 4B)17
• This results in vHipp MRs – which are thought to be inhibitory
– having a more pronounced effect during AMP WD.
• This suggests CORT activation of vHipp MRs may mediate the
reduction in accumbal dopamine output during withdrawal.
To uncover the underlying receptor mechanisms (of the findings in Fig
3), we are currently testing whether these differential stress responses
can be inhibited by separate infusions of GR and MR antagonists.
Significance
Overall, findings suggest the neural corticosterone system could
play an important role in driving positive stress coping
mechanisms in healthy conditions, with dysregulation of this
system potentially contributing to relapse during AMP WD.
1. Hollon, N.G. et al. (2015). Nature Neuroscience, 18(10).
2. Koob, G.F. (2015). Eur J Pharmacol, 753.
3. Cleck, J.N & Blendy, J.A. (2008). J Clinical Investivation, 118(2).
4. Shoptaw, S.J. et al. (2009). Cochrane Database Syst Rev, (2).
5. Bray et al. (2016). Brain Res, in revision.
6. Barr, J. L., et al. (2010). Neuropharmacology, 59(6).
7. Li, H. et al. (2014). Eur J Neurosci, 40(11)
8. Tu, W. et al. (2014). Neuroscience, 281c.
9. Vuong, S. M., et al. (2010). Behav Brain Res, 208(1).
10. Russig, H. et al. (2006). Brain Res, 1084(1).
11. Wang, C.C. & Wang, S.J. (2009). Synapse, 63(9).
12. Karst, H. et al. (2005). Proc of Nat Acad Sci USA, 102(52).
13. Blaha, C.D. et al. (1997). Eur J Neurosci, 9(5).
14. Floresco, S.B. (2014). Ann Rev Psych.
15. Barr, J.L. et al. (2014). J Neurochemistry, 130(4).
16. Taepavarapruk, P. et al. (2014). Int J Neurospchypharm, 18(1).
17. Barr, J.L. & Forster, G.L. (2011). Neuroscience, 182.
18. Droste, S.K. et al. (2008). Endocrinology, 149(7).
19. Novick, A.M. et al. (2015). Neuropharmacol, 97.
20. Miller et al. (2005). Neurosci, 136(2).
21. Paxinos, G.W.C. (1998). Rat Brain in Stereotaxic Coordinates, 4e.
22. Borland, L. & Michael A., (2007). Electrochem Met Neurosci.
Saline
Amphetamine
HippocampalCorticosterone
(%baseline)
Ventral
Hippocampus
Time (min)
Restraint
Glutamate (+)
GABA (-)
Enhanced vHipp CORT stress response proposed to enhance accumbal dopamine output
Fig 2A5 : Rats undergoing amphetamine withdrawal (n=7) show enhanced
CORT in the vHipp in response to 20 min of restraint stress (marked by
horizontal bar), relative to saline pre-treated controls (n=6). # Significant
difference from pre-stress levels. *Significant difference from saline rats5.
Fig 2B14 : CORT in the vHipp can induce glutamate
release11-12 and the vHipp sends glutamatergic
projections to the nucleus accumbens13-14 to enhance
dopamine output and reward salience13-16.
Opponent-Process Theory of Addiction, Altered GR/MR expression in AMP WD
GROpticalDensity
GR/MRRatio
Fig 4B17: vHipp GR expression (left) and
GR/MR expression ratio (right) are reduced
during AMP WD17, resulting in MRs having
more pronounced (inhibitory) effect in WD.
Fig 4A2: In an opponent-process theory of addiction, drug-induced dopamine
reward responses (a) are positively reinforcing, but become blunted over time.
Increased corticosterone stress responses in withdrawal (b) negatively reinforce
drug-taking and worsen over time2, which may contribute to relapse.
-40 -20 0 20 40 60 80 100 120
-0.6
-0.4
-0.2
0.0
0.2
0.4
0.6
0.8
1.0
SAL + VEH (n=6)
AMP + VEH (n=6)
AMP + CORT (n=7)
SAL + CORT (n=7)
Time (min)
DopamineOxidationCurrent(nA)
Infusion
Fig 3: vHipp CORT enhances accumbal dopamine
output in drug-naïve rats (green tracing), peaking 55
min post infusion (n=7).
• This suggests a novel mechanism by which stress
exposure could enhance reward value to
promote goal-oriented behavior1,14 (Fig 1).
vHipp CORT immediately reduces accumbal
dopamine output in AMP WD (red tracing), peaking
20 min and then 80 min post infusion (n=7).
• This suggests stress-induced vHipp CORT could
contribute to dysphoric states that prompt drug-
seeking and relapse during withdrawal2-4 (Fig 4A).
Background
• Stress can motivate goal-oriented behavior (Fig 1) but can also
prompt drug use and induce relapse during withdrawal (Fig 4A)1-3.
• Amphetamine withdrawal (AMP WD) is associated with dysphoria4
and stress hypersensitivity4-10 that can prompt relapse (Fig 4A)2-4.
• In rats, AMP WD is associated with enhanced stress-induced
corticosterone (CORT) in the ventral hippocampus (vHipp), which
may contribute to stress hypersensitivity during WD (Fig 2A)5.
• CORT in the vHipp can induce glutamate release11-12 and the vHipp
sends glutamatergic projections to the nucleus accumbens13-14 to
enhance dopamine output13-15 and reward salience (Fig 2B)14,16.
• It remains unknown whether a stress-relevant concentration of
CORT in the vHipp can directly enhance accumbal dopamine output
in control conditions, and during AMP WD.
Methods
Rodent Model of AMP Withdrawal:
Adult male Sprague-Dawley rats were treated with AMP (2.5 mg/kg, ip) or saline (SAL)
for 2 weeks5-9, then underwent 2 weeks of withdrawal 5-9.
● This protocol is known to enhance behavioral responses to stress7
Stereotactic Surgery:
Stereotactic surgery was performed in the 2nd week of withdrawal8-9:
● A stearate-treated carbon paste electrode19 was implanted into the
nucleus accumbens shell (1.6mm AP; ±0.7mm ML; -7.0mm DV)20,21
● A 22-guage guide cannula was implanted into the vHipp (-5.2mm AP;
±4.5mm ML; -4.5mm DV)8,21
Intracranial Infusion:
A stress-relevant concentration of CORT (0.48 ng/uL)17 or vehicle (0.05% HBC)
was infused into the vHipp (1uL total at flow rate 1uL/min, ipsilateral to the
carbon paste electrode in the nucleus accumbens) of anesthetized drug-naïve
rats and rats in AMP WD to mimic the vHipp CORT stress response5,18.
In vivo Chronoamperometry19,22:
In vivo chronoamperometry was used to assess accumbal dopamine output:
A fixed pulse potential was applied to the working electrode (implanted into the
nucleus accumbens shell), resulting in dopamine oxidation19,22.
The oxidation current was recorded by an electrometer and plotted as a function of
time (min) before, during, and after the vHipp CORT infusion19,22.
http://www.strictly-stress-management.com/types_of_stress.html
Fig 1: Optimal levels of stress motivate goal-oriented behavior.
Differential effects of vHipp CORT on accumbal dopamine output in controls and in AMP WD

More Related Content

What's hot

Dextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCADextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCAMark Henderson, Ph.D.
 
Natural bioactive compounds promotes neurohealth
Natural bioactive compounds promotes neurohealthNatural bioactive compounds promotes neurohealth
Natural bioactive compounds promotes neurohealth
VIJAYRAJA DHANRAJ
 
Presentation Seminar in Novara University Italy
Presentation Seminar in Novara University ItalyPresentation Seminar in Novara University Italy
Presentation Seminar in Novara University Italy
Georgios Deraos
 
Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...
Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...
Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...
Ben Decker
 
Sigma Xi Presentation
Sigma Xi PresentationSigma Xi Presentation
Sigma Xi Presentationmbusel
 
Sigma xi presentation
Sigma xi presentationSigma xi presentation
Sigma xi presentationmbusel
 
Sigma Xi Presentation
Sigma Xi PresentationSigma Xi Presentation
Sigma Xi Presentationmbusel
 
SfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinSfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinPierre Zwiegers
 
Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16John Gruner
 
Neurochemistry of defensive behavior in zebrafish
Neurochemistry of defensive behavior in zebrafishNeurochemistry of defensive behavior in zebrafish
Neurochemistry of defensive behavior in zebrafish
Caio Maximino
 
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
ChemAxon
 
9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...
9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...
9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...
Lucas Aoun
 
Cristallo, Tara Murdock Conference Poster
Cristallo, Tara Murdock Conference PosterCristallo, Tara Murdock Conference Poster
Cristallo, Tara Murdock Conference PosterTara Cristallo
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
Brian Piper
 
The Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
The Effect of Losartan on Deformities Occurring in Brain Tissue CraniectomyThe Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
The Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
ANALYTICAL AND QUANTITATIVE CYTOPATHOLOGY AND HISTOPATHOLOGY
 
Drug screening
Drug screeningDrug screening
Drug screening
Steven Wong
 

What's hot (19)

Dextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCADextromethorphan antagonizes acute 5HT depletion by PCA
Dextromethorphan antagonizes acute 5HT depletion by PCA
 
Natural bioactive compounds promotes neurohealth
Natural bioactive compounds promotes neurohealthNatural bioactive compounds promotes neurohealth
Natural bioactive compounds promotes neurohealth
 
Presentation Seminar in Novara University Italy
Presentation Seminar in Novara University ItalyPresentation Seminar in Novara University Italy
Presentation Seminar in Novara University Italy
 
Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...
Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...
Molecular Characterization of Polyglucosan Body, Cause or Consequence in the ...
 
Sigma Xi Presentation
Sigma Xi PresentationSigma Xi Presentation
Sigma Xi Presentation
 
Sigma xi presentation
Sigma xi presentationSigma xi presentation
Sigma xi presentation
 
Sigma Xi Presentation
Sigma Xi PresentationSigma Xi Presentation
Sigma Xi Presentation
 
SfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_ProgranulinSfN 2008_Tabata_CruzAguado_Progranulin
SfN 2008_Tabata_CruzAguado_Progranulin
 
EASD 2009
EASD 2009EASD 2009
EASD 2009
 
ACCP publication
ACCP publication ACCP publication
ACCP publication
 
Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16Marinus GNX SFN poster 16Nov16
Marinus GNX SFN poster 16Nov16
 
GaborSRPPoster JM edits
GaborSRPPoster JM editsGaborSRPPoster JM edits
GaborSRPPoster JM edits
 
Neurochemistry of defensive behavior in zebrafish
Neurochemistry of defensive behavior in zebrafishNeurochemistry of defensive behavior in zebrafish
Neurochemistry of defensive behavior in zebrafish
 
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
EUGM15 - Zoltán Simon (Printnet): Drug Profile Matching - Drug Discovery by P...
 
9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...
9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...
9-methyl-β-carboline (9-MBC): Nootropic Properties, Dopamine Enhancer and Res...
 
Cristallo, Tara Murdock Conference Poster
Cristallo, Tara Murdock Conference PosterCristallo, Tara Murdock Conference Poster
Cristallo, Tara Murdock Conference Poster
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
 
The Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
The Effect of Losartan on Deformities Occurring in Brain Tissue CraniectomyThe Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
The Effect of Losartan on Deformities Occurring in Brain Tissue Craniectomy
 
Drug screening
Drug screeningDrug screening
Drug screening
 

Similar to Sanford Symposium 2016 Poster FINAL

ScienceFestival 2016 Poster FINAL
ScienceFestival 2016 Poster FINALScienceFestival 2016 Poster FINAL
ScienceFestival 2016 Poster FINALBrenna Bray
 
safety of oral ketamine
safety of oral ketaminesafety of oral ketamine
safety of oral ketaminearbin joshi
 
POSTER BIOL 499 (Uyen)
POSTER BIOL 499 (Uyen)POSTER BIOL 499 (Uyen)
POSTER BIOL 499 (Uyen)Uyen Hoang
 
Cell_Metabolism_Credit
Cell_Metabolism_CreditCell_Metabolism_Credit
Cell_Metabolism_CreditYikun Guo
 
The Two Component Stressors
The Two Component StressorsThe Two Component Stressors
The Two Component Stressors
Patricia Viljoen
 
Epilepsy Poster titiu
Epilepsy Poster titiuEpilepsy Poster titiu
Epilepsy Poster titiuTamana Yousof
 
20101027 新光醫院精神科Speech
20101027 新光醫院精神科Speech20101027 新光醫院精神科Speech
20101027 新光醫院精神科Speech
潘 建志
 
Hippocampal ltp and contextual learning require surface diffusion of ampa rec...
Hippocampal ltp and contextual learning require surface diffusion of ampa rec...Hippocampal ltp and contextual learning require surface diffusion of ampa rec...
Hippocampal ltp and contextual learning require surface diffusion of ampa rec...
Masuma Sani
 
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University Marie-Laure Rives, PhD
 
Citalopram improves response inhibition in more severe Parkinson’s disease
Citalopram improves response inhibition in more severe Parkinson’s diseaseCitalopram improves response inhibition in more severe Parkinson’s disease
Citalopram improves response inhibition in more severe Parkinson’s disease
Zheng Ye
 
CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1Stacia Lewandowski
 
art%3A10.1007%2Fs00213-014-3657-4
art%3A10.1007%2Fs00213-014-3657-4art%3A10.1007%2Fs00213-014-3657-4
art%3A10.1007%2Fs00213-014-3657-4Natalia K?eczek
 
Molecular mechanism underlying Depression: The relationship between serotonin...
Molecular mechanism underlying Depression: The relationship between serotonin...Molecular mechanism underlying Depression: The relationship between serotonin...
Molecular mechanism underlying Depression: The relationship between serotonin...
Adiba shabnam
 
Clinical pharmacology of DP-b99 in healthy volunteers
Clinical pharmacology of DP-b99 in healthy volunteersClinical pharmacology of DP-b99 in healthy volunteers
Clinical pharmacology of DP-b99 in healthy volunteersAdina Chen Bar
 
presentation-presentation-biomarkers-arthur-burghes_en.pdf
presentation-presentation-biomarkers-arthur-burghes_en.pdfpresentation-presentation-biomarkers-arthur-burghes_en.pdf
presentation-presentation-biomarkers-arthur-burghes_en.pdf
MuhammadTanveer231769
 
Bio se en_2008_1+bareme
Bio se en_2008_1+baremeBio se en_2008_1+bareme
Bio se en_2008_1+bareme
Lara El Feghali
 

Similar to Sanford Symposium 2016 Poster FINAL (20)

ScienceFestival 2016 Poster FINAL
ScienceFestival 2016 Poster FINALScienceFestival 2016 Poster FINAL
ScienceFestival 2016 Poster FINAL
 
Caryne Stacia Neuropharm
Caryne Stacia NeuropharmCaryne Stacia Neuropharm
Caryne Stacia Neuropharm
 
safety of oral ketamine
safety of oral ketaminesafety of oral ketamine
safety of oral ketamine
 
POSTER BIOL 499 (Uyen)
POSTER BIOL 499 (Uyen)POSTER BIOL 499 (Uyen)
POSTER BIOL 499 (Uyen)
 
Cell_Metabolism_Credit
Cell_Metabolism_CreditCell_Metabolism_Credit
Cell_Metabolism_Credit
 
The Two Component Stressors
The Two Component StressorsThe Two Component Stressors
The Two Component Stressors
 
Epilepsy Poster titiu
Epilepsy Poster titiuEpilepsy Poster titiu
Epilepsy Poster titiu
 
20101027 新光醫院精神科Speech
20101027 新光醫院精神科Speech20101027 新光醫院精神科Speech
20101027 新光醫院精神科Speech
 
Hippocampal ltp and contextual learning require surface diffusion of ampa rec...
Hippocampal ltp and contextual learning require surface diffusion of ampa rec...Hippocampal ltp and contextual learning require surface diffusion of ampa rec...
Hippocampal ltp and contextual learning require surface diffusion of ampa rec...
 
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
Marie-Laure Rives Allostery Functional Selectivity KOR Columbia University
 
Citalopram improves response inhibition in more severe Parkinson’s disease
Citalopram improves response inhibition in more severe Parkinson’s diseaseCitalopram improves response inhibition in more severe Parkinson’s disease
Citalopram improves response inhibition in more severe Parkinson’s disease
 
CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1CPC PENN Stress Meeting 2012_1
CPC PENN Stress Meeting 2012_1
 
art%3A10.1007%2Fs00213-014-3657-4
art%3A10.1007%2Fs00213-014-3657-4art%3A10.1007%2Fs00213-014-3657-4
art%3A10.1007%2Fs00213-014-3657-4
 
Molecular mechanism underlying Depression: The relationship between serotonin...
Molecular mechanism underlying Depression: The relationship between serotonin...Molecular mechanism underlying Depression: The relationship between serotonin...
Molecular mechanism underlying Depression: The relationship between serotonin...
 
Clinical pharmacology of DP-b99 in healthy volunteers
Clinical pharmacology of DP-b99 in healthy volunteersClinical pharmacology of DP-b99 in healthy volunteers
Clinical pharmacology of DP-b99 in healthy volunteers
 
kellyoh_sciencepub
kellyoh_sciencepubkellyoh_sciencepub
kellyoh_sciencepub
 
06_IJPBA_2083_23.pdf
06_IJPBA_2083_23.pdf06_IJPBA_2083_23.pdf
06_IJPBA_2083_23.pdf
 
presentation-presentation-biomarkers-arthur-burghes_en.pdf
presentation-presentation-biomarkers-arthur-burghes_en.pdfpresentation-presentation-biomarkers-arthur-burghes_en.pdf
presentation-presentation-biomarkers-arthur-burghes_en.pdf
 
Bio se en_2008_1+bareme
Bio se en_2008_1+baremeBio se en_2008_1+bareme
Bio se en_2008_1+bareme
 
SFN Poster 10.11.15
SFN Poster 10.11.15SFN Poster 10.11.15
SFN Poster 10.11.15
 

Sanford Symposium 2016 Poster FINAL

  • 1. Ventral hippocampal corticosterone: Linking stress, accumbal dopamine output, and reward salience in healthy conditions and in amphetamine withdrawal Brenna Bray, Matthew Weber, and Gina L. Forster Center for Brain and Behavior Research, Basic Biomedical Sciences, Sanford School of Medicine, University of South Dakota References Acknowledgements Grant support: NIH grant RO1 DA019921. Special thanks to Jamie Scholl, Michael Watt, PhD, Wenyu Tu, Dana Turgeon, and Raisul Rubel for their invaluable help. Conclusions • In drug-naive rats, vHipp CORT enhances accumbal dopamine output, peaking 55 min post infusion (Fig 3). • This suggests a novel mechanism by which stress exposure could enhance reward value to promote goal-oriented behavior1,14 (Fig 1). • In AMP WD, vHipp CORT immediately reduces accumbal dopamine output, peaking 20 min and then 80 min post-infusion (Fig 3). • This suggests stress-induced vHipp CORT could contribute to dysphoric states that prompt drug-seeking and relapse during withdrawal (Fig 4A)2-4. • These findings support an opponent-process theory of addiction, in which blunted dopamine reward responses and enhanced CORT stress responses contribute to negative reinforcement of drug-taking (Fig 4A)2. Discussion • CORT activation of glucocorticoid receptors (GRs) is thought to be excitatory in the vHipp7-8,11,, implicating GRs as the underlying mechanism for the CORT-induced dopamine output (Fig 3). • GR expression is reduced in the vHipp during AMP WD, but vHipp mineralocorticoid receptor (MR) expression is not altered (Fig 4B)17 • This results in vHipp MRs – which are thought to be inhibitory – having a more pronounced effect during AMP WD. • This suggests CORT activation of vHipp MRs may mediate the reduction in accumbal dopamine output during withdrawal. To uncover the underlying receptor mechanisms (of the findings in Fig 3), we are currently testing whether these differential stress responses can be inhibited by separate infusions of GR and MR antagonists. Significance Overall, findings suggest the neural corticosterone system could play an important role in driving positive stress coping mechanisms in healthy conditions, with dysregulation of this system potentially contributing to relapse during AMP WD. 1. Hollon, N.G. et al. (2015). Nature Neuroscience, 18(10). 2. Koob, G.F. (2015). Eur J Pharmacol, 753. 3. Cleck, J.N & Blendy, J.A. (2008). J Clinical Investivation, 118(2). 4. Shoptaw, S.J. et al. (2009). Cochrane Database Syst Rev, (2). 5. Bray et al. (2016). Brain Res, in revision. 6. Barr, J. L., et al. (2010). Neuropharmacology, 59(6). 7. Li, H. et al. (2014). Eur J Neurosci, 40(11) 8. Tu, W. et al. (2014). Neuroscience, 281c. 9. Vuong, S. M., et al. (2010). Behav Brain Res, 208(1). 10. Russig, H. et al. (2006). Brain Res, 1084(1). 11. Wang, C.C. & Wang, S.J. (2009). Synapse, 63(9). 12. Karst, H. et al. (2005). Proc of Nat Acad Sci USA, 102(52). 13. Blaha, C.D. et al. (1997). Eur J Neurosci, 9(5). 14. Floresco, S.B. (2014). Ann Rev Psych. 15. Barr, J.L. et al. (2014). J Neurochemistry, 130(4). 16. Taepavarapruk, P. et al. (2014). Int J Neurospchypharm, 18(1). 17. Barr, J.L. & Forster, G.L. (2011). Neuroscience, 182. 18. Droste, S.K. et al. (2008). Endocrinology, 149(7). 19. Novick, A.M. et al. (2015). Neuropharmacol, 97. 20. Miller et al. (2005). Neurosci, 136(2). 21. Paxinos, G.W.C. (1998). Rat Brain in Stereotaxic Coordinates, 4e. 22. Borland, L. & Michael A., (2007). Electrochem Met Neurosci. Saline Amphetamine HippocampalCorticosterone (%baseline) Ventral Hippocampus Time (min) Restraint Glutamate (+) GABA (-) Enhanced vHipp CORT stress response proposed to enhance accumbal dopamine output Fig 2A5 : Rats undergoing amphetamine withdrawal (n=7) show enhanced CORT in the vHipp in response to 20 min of restraint stress (marked by horizontal bar), relative to saline pre-treated controls (n=6). # Significant difference from pre-stress levels. *Significant difference from saline rats5. Fig 2B14 : CORT in the vHipp can induce glutamate release11-12 and the vHipp sends glutamatergic projections to the nucleus accumbens13-14 to enhance dopamine output and reward salience13-16. Opponent-Process Theory of Addiction, Altered GR/MR expression in AMP WD GROpticalDensity GR/MRRatio Fig 4B17: vHipp GR expression (left) and GR/MR expression ratio (right) are reduced during AMP WD17, resulting in MRs having more pronounced (inhibitory) effect in WD. Fig 4A2: In an opponent-process theory of addiction, drug-induced dopamine reward responses (a) are positively reinforcing, but become blunted over time. Increased corticosterone stress responses in withdrawal (b) negatively reinforce drug-taking and worsen over time2, which may contribute to relapse. -40 -20 0 20 40 60 80 100 120 -0.6 -0.4 -0.2 0.0 0.2 0.4 0.6 0.8 1.0 SAL + VEH (n=6) AMP + VEH (n=6) AMP + CORT (n=7) SAL + CORT (n=7) Time (min) DopamineOxidationCurrent(nA) Infusion Fig 3: vHipp CORT enhances accumbal dopamine output in drug-naïve rats (green tracing), peaking 55 min post infusion (n=7). • This suggests a novel mechanism by which stress exposure could enhance reward value to promote goal-oriented behavior1,14 (Fig 1). vHipp CORT immediately reduces accumbal dopamine output in AMP WD (red tracing), peaking 20 min and then 80 min post infusion (n=7). • This suggests stress-induced vHipp CORT could contribute to dysphoric states that prompt drug- seeking and relapse during withdrawal2-4 (Fig 4A). Background • Stress can motivate goal-oriented behavior (Fig 1) but can also prompt drug use and induce relapse during withdrawal (Fig 4A)1-3. • Amphetamine withdrawal (AMP WD) is associated with dysphoria4 and stress hypersensitivity4-10 that can prompt relapse (Fig 4A)2-4. • In rats, AMP WD is associated with enhanced stress-induced corticosterone (CORT) in the ventral hippocampus (vHipp), which may contribute to stress hypersensitivity during WD (Fig 2A)5. • CORT in the vHipp can induce glutamate release11-12 and the vHipp sends glutamatergic projections to the nucleus accumbens13-14 to enhance dopamine output13-15 and reward salience (Fig 2B)14,16. • It remains unknown whether a stress-relevant concentration of CORT in the vHipp can directly enhance accumbal dopamine output in control conditions, and during AMP WD. Methods Rodent Model of AMP Withdrawal: Adult male Sprague-Dawley rats were treated with AMP (2.5 mg/kg, ip) or saline (SAL) for 2 weeks5-9, then underwent 2 weeks of withdrawal 5-9. ● This protocol is known to enhance behavioral responses to stress7 Stereotactic Surgery: Stereotactic surgery was performed in the 2nd week of withdrawal8-9: ● A stearate-treated carbon paste electrode19 was implanted into the nucleus accumbens shell (1.6mm AP; ±0.7mm ML; -7.0mm DV)20,21 ● A 22-guage guide cannula was implanted into the vHipp (-5.2mm AP; ±4.5mm ML; -4.5mm DV)8,21 Intracranial Infusion: A stress-relevant concentration of CORT (0.48 ng/uL)17 or vehicle (0.05% HBC) was infused into the vHipp (1uL total at flow rate 1uL/min, ipsilateral to the carbon paste electrode in the nucleus accumbens) of anesthetized drug-naïve rats and rats in AMP WD to mimic the vHipp CORT stress response5,18. In vivo Chronoamperometry19,22: In vivo chronoamperometry was used to assess accumbal dopamine output: A fixed pulse potential was applied to the working electrode (implanted into the nucleus accumbens shell), resulting in dopamine oxidation19,22. The oxidation current was recorded by an electrometer and plotted as a function of time (min) before, during, and after the vHipp CORT infusion19,22. http://www.strictly-stress-management.com/types_of_stress.html Fig 1: Optimal levels of stress motivate goal-oriented behavior. Differential effects of vHipp CORT on accumbal dopamine output in controls and in AMP WD